MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

November 14, 2017

Ministers from the eleven countries assessing the Trans-Pacific Partnership (TPP) trade deal have suspended many of the damaging provisions that would have restricted access to medicines and vaccines, a victory for millions of people who rely on affordable medicines worldwide.

March 21, 2017

Winile is a multidrug-resistant tuberculosis (MDR-TB) patient with Doctors Without Borders/Médecins Sans Frontières (MSF) in Swaziland, and one of the many who have lost their hearing due to the toxicity of available MDR-TB drugs. Through an MSF program in Swaziland, she has learned sign language so she can continue to communicate.

February 23, 2017

"You see, I am healed," says Tholakele as she walks around her ward demonstrating her recovery. "Even my legs don't give me problems anymore. Now I can walk perfectly. I walk around the hospital; go out for fresh air and come back when I’m ready."

Tholakele, 39, has drug-resistant tuberculosis (DR-TB) and started treatment in May 2016 at the Moneni National TB Hospital, supported by Doctors Without Borders/Médecins Sans Frontières (MSF) in central Swaziland.

May 26, 2016

New York/Ise-Shima/Geneva—As the leaders of the G7 countries gather in Ise-Shima, Japan over the next two days, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to make a bold commitment to prioritize a better global response to public health emergencies and to take action to encourage the research and development (R&D) and affordable pricing of critical medicines.

April 21, 2016

The earthquakes that ratted southwestern Japan last week injured around 1,100 people in Kumamoto and Oita prefectures and led to the deaths of another 58. Roughly 103,000 people remained displaced in Kumamoto and around 600 in Oita, and the authorities are still searching for people who are unaccounted for as well. What's more, due to heavy rains and the subsequent risk of landslides, some 240,000 people have been advised to evacuate 19 cities, towns and villages in Kumamoto and Oita.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

August 05, 2015

In places with high HIV or tuberculosis (TB) burdens and significant shortages of human resources for health care work, lay counsellors have become extremely important. They provide HIV testing and counselling and help patients get through difficult challenges in adhering to HIV and TB treatments. But their crucial involvement in treatment programs is critically underfunded.

March 19, 2015

Doctors Without Borders and research center in Borstel, Germany, publish findings in New England Journal of Medicine.

August 28, 2014

To try to meet the needs, MSF is training staff before they fly out to various projects, as there is little time for training once they arrive.

July 25, 2014

 

Thirty-five-year-old Khanyi proudly holds her certificate, which reads “I got tested and cured of TB." A mother of two, Khanyi lives in Logoba, an overcrowded informal settlement in central Swaziland near the industrial town of Matsapha.

Three years ago, while taking care of her diabetic husband, who is also co-infected with HIV and tuberculosis (TB), Khanyi was herself diagnosed with TB.

Pages

November 14, 2017

Ministers from the eleven countries assessing the Trans-Pacific Partnership (TPP) trade deal have suspended many of the damaging provisions that would have restricted access to medicines and vaccines, a victory for millions of people who rely on affordable medicines worldwide.

March 21, 2017

Winile is a multidrug-resistant tuberculosis (MDR-TB) patient with Doctors Without Borders/Médecins Sans Frontières (MSF) in Swaziland, and one of the many who have lost their hearing due to the toxicity of available MDR-TB drugs. Through an MSF program in Swaziland, she has learned sign language so she can continue to communicate.

February 23, 2017

"You see, I am healed," says Tholakele as she walks around her ward demonstrating her recovery. "Even my legs don't give me problems anymore. Now I can walk perfectly. I walk around the hospital; go out for fresh air and come back when I’m ready."

Tholakele, 39, has drug-resistant tuberculosis (DR-TB) and started treatment in May 2016 at the Moneni National TB Hospital, supported by Doctors Without Borders/Médecins Sans Frontières (MSF) in central Swaziland.

May 26, 2016

New York/Ise-Shima/Geneva—As the leaders of the G7 countries gather in Ise-Shima, Japan over the next two days, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to make a bold commitment to prioritize a better global response to public health emergencies and to take action to encourage the research and development (R&D) and affordable pricing of critical medicines.

April 21, 2016

The earthquakes that ratted southwestern Japan last week injured around 1,100 people in Kumamoto and Oita prefectures and led to the deaths of another 58. Roughly 103,000 people remained displaced in Kumamoto and around 600 in Oita, and the authorities are still searching for people who are unaccounted for as well. What's more, due to heavy rains and the subsequent risk of landslides, some 240,000 people have been advised to evacuate 19 cities, towns and villages in Kumamoto and Oita.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

August 05, 2015

In places with high HIV or tuberculosis (TB) burdens and significant shortages of human resources for health care work, lay counsellors have become extremely important. They provide HIV testing and counselling and help patients get through difficult challenges in adhering to HIV and TB treatments. But their crucial involvement in treatment programs is critically underfunded.

March 19, 2015

Doctors Without Borders and research center in Borstel, Germany, publish findings in New England Journal of Medicine.

August 28, 2014

To try to meet the needs, MSF is training staff before they fly out to various projects, as there is little time for training once they arrive.

July 25, 2014

 

Thirty-five-year-old Khanyi proudly holds her certificate, which reads “I got tested and cured of TB." A mother of two, Khanyi lives in Logoba, an overcrowded informal settlement in central Swaziland near the industrial town of Matsapha.

Three years ago, while taking care of her diabetic husband, who is also co-infected with HIV and tuberculosis (TB), Khanyi was herself diagnosed with TB.

Pages